It has been reported that serum 25-hydroxyvitamin D3 levels are reduced in patients with psoriasis or psoriatic arthritis compared to controls [47] and that the expression of VDR is decreased in psoriatic skin lesions [48]. This evidence concerns the gene VDR and psoriasis.